Shares of Select Medical Holdings Co. (NYSE:SEM) have received an average recommendation of “Hold” from the ten brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $19.60.

SEM has been the subject of a number of recent research reports. ValuEngine raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Royal Bank of Canada reissued a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a research note on Wednesday, September 13th. Zacks Investment Research downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Robert W. Baird reissued a “buy” rating and issued a $21.00 price objective on shares of Select Medical in a research note on Tuesday, October 17th. Finally, Deutsche Bank reaffirmed a “buy” rating and issued a $22.00 price target on shares of Select Medical in a report on Monday, November 6th.

In related news, insider Martin F. Jackson sold 156,603 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total transaction of $2,671,647.18. Following the completion of the transaction, the insider now directly owns 1,790,601 shares in the company, valued at $30,547,653.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Scott A. Romberger sold 5,000 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total transaction of $89,850.00. Following the transaction, the insider now owns 168,211 shares of the company’s stock, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders have sold 180,103 shares of company stock worth $3,112,442 over the last three months. Corporate insiders own 19.93% of the company’s stock.

Several institutional investors have recently modified their holdings of the business. Cubist Systematic Strategies LLC acquired a new position in shares of Select Medical in the third quarter worth about $1,748,000. Point72 Asset Management L.P. acquired a new position in shares of Select Medical during the 3rd quarter worth about $20,751,000. Affinity Wealth Management purchased a new stake in Select Medical during the 3rd quarter valued at about $429,000. Orbimed Advisors LLC grew its stake in Select Medical by 51.3% during the 3rd quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock valued at $107,107,000 after acquiring an additional 1,891,100 shares in the last quarter. Finally, Jane Street Group LLC purchased a new stake in Select Medical during the 3rd quarter valued at about $1,176,000. Institutional investors and hedge funds own 77.93% of the company’s stock.

Shares of Select Medical (NYSE SEM) traded down $0.10 during midday trading on Thursday, reaching $16.75. 981,108 shares of the company’s stock traded hands, compared to its average volume of 884,490. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 3.36. The company has a market capitalization of $2,241.56, a P/E ratio of 21.20, a P/E/G ratio of 1.31 and a beta of 1.35. Select Medical has a twelve month low of $12.00 and a twelve month high of $19.77.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the firm posted $0.06 EPS. The business’s revenue was up 4.1% on a year-over-year basis. research analysts predict that Select Medical will post 0.85 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Select Medical Holdings Co. (SEM) Receives Average Recommendation of “Hold” from Analysts” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/14/select-medical-holdings-co-sem-receives-average-recommendation-of-hold-from-analysts.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.